What's happening with the Medibank share price today?

Medibank made a commitment at the start of the pandemic that it would not profit from COVID-19.

| More on:
excited young female in business attire and wearing glasses is holding up $100 notes in both hands.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Medibank Private Ltd (ASX: MPL) share price is slightly in the green in early morning trade on Thursday.

Shares in the S&P/ASX 200 Index (ASX: XJO) healthcare stock closed yesterday trading for $3.50. Shares are currently changing hands for $3.505, up 0.14%.

This comes after Australia's biggest health insurer updated the market on its ongoing COVID-19 support package and give-back program.

What did the ASX 200 health insurer report?

In an announcement unlikely to have a direct material impact on the Medibank share price today, the health insurer announced it would return another $125 million to its customers.

Medibank has now provided $1.15 billion in support to its customers since the start of the global pandemic in early 2020.

The company said its customers would receive funds directly in their bank accounts. The new round of support will be up to $91 for extras-only policies and up to $402 for hospital and extras policies.

Medibank and ahm customers can expect those funds by October.

The cash return is funded from additional COVID-19 permanent net claims savings. Management said it would not impact the insurer's operating earnings for H1 2023. This is why I don't expect the new round of support funds will drag on the Medicare share price.

Commenting on the support package, group executive Milosh Milisavljevic said, "We have now given back $1.15 billion to customers through our COVID-19 give-back program since the start of the pandemic."

Milisavljevic continued:

This year alone we have returned $408 million to customers through cash backs, premium increase deferrals and rolling over extras limits. At a time when people are really feeling the pinch of cost-of-living pressures, we know this extra cash in their pocket will be welcomed.

We made a commitment at the start of the pandemic that we would not profit from COVID-19, and we've stuck by that promise.

Clients holding an active hospital and/or extras policy at any time during the first half of 2023 will be eligible for some portion of the cash-back package.

Medibank share price snapshot

The Medibank share price has been a strong performer in 2023, up 21% year to date.

Motley Fool contributor Bernd Struben has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Healthcare Shares

Scientist looking at a laptop thinking about the share price performance.
Healthcare Shares

Mesoblast just cleared a key FDA hurdle. So why are investors exiting?

Mesoblast shares slide to a 2-month low despite positive FDA feedback on its lead cell therapy product.

Read more »

Man leaps as he runs along the street.
Healthcare Shares

ASX 300 stock jumps 6% on strong half-year results and cash flow surge

Let's see how this medical device company performed during the first half.

Read more »

Two boys lie in the grass arm wrestling.
Healthcare Shares

Is CSL or Sonic Healthcare the smarter ASX healthcare share buy?

This ASX heavyweight has potential to deliver superior returns but is more volatile.

Read more »

Doctor sees virtual images of the patient's x-rays on a blue background.
Healthcare Shares

Up more than 800% in a year. Why this ASX medical tech stock just hit an all-time high

4DMedical shares have surged over 800% as US hospital adoption and FDA clearance drive momentum.

Read more »

A retiree relaxing in the pool and giving a thumbs up.
Healthcare Shares

1 ASX dividend stock down 36% I'd buy right now

This business looks like it’s priced too cheaply.

Read more »

Researchers and doctors with futuristic 3d hologram overlay for body anatomy or dna in hospital clinic.
Healthcare Shares

Why investors are watching this ASX healthcare stock

A fresh clinical update has been released.

Read more »

A Sonic Healthcare medical researcher wearing a white coat sits at her desk in a laboratory conducting a COVID-19 test
Healthcare Shares

This biotech is up more than 20% on new deal news

Revenue will flow under this global deal just announced.

Read more »

A male doctor and a woman in scrubs in the foreground smile.
Healthcare Shares

The next 3 years could be huge for this ASX healthcare stock. Here's why

Today's update has put this ASX healthcare stock back in the spotlight as investors reassess its long-term growth potential.

Read more »